china resources

As Blackrock reportedly exits stage left, all eyes turn to Baoneng, which is likely to be the next to sell out of the Chinese property developer.

Luye Pharma Group has agreed to buy a subsidiary of Swiss counterpart Acino, becoming the latest Chinese healthcare company to look overseas for expansion.

The share price dips 9.1% in morning trading after the deal is priced at an aggressive 8.2% discount.

China Resources Enterprise pays $42 million to buy a majority stake in Pacific Coffee from Chevalier Pacific, earning Chevalier a healthy return on its five-year investment.